Clinical Trials Sponsored by CVSS study

Total 1342 results

CSSS de Gatineau

Active, not recruiting

Study of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate Cancer

Prostate Cancer

Canada
Pfizer
CVS Caremark

Completed

Patient Reported Health-Related Quality of Life Associated With COVID-19

COVID-19

United States
Terumo CVS
Vascutek Ltd.

Completed

The Vascutek AnacondaTM Stent Graft System Phase II IDE Study

Infrarenal Abdominal Aortic Aneurysm

Canada, United States
CR-CSSS Champlain-Charles-Le Moyne

Suspended

Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate Cancer (BRP30)

Prostate Cancer

Canada
CR-CSSS Champlain-Charles-Le Moyne

Completed

HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer (BRP2)

Prostate Cancer

Canada
Danish Study Group

Not yet recruiting

Coronary Artery Bypass Grafts or Percutaneous Coronary Intervention for High Risk Patients

LV Dysfunction | IHD

Denmark
Lymphoma Study Association

Completed

R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma

Lymphoma, Large-Cell, Diffuse

United States, Australia, Belgium, Czechia, Finland, Germany, Israel, Sweden, Switzerland, United Kingdom
Lymphoma Study Association

Completed

Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's Lymphoma

Follicular Lymphoma

France
Lymphoma Study Association

Completed

Mini-CHOP and Rituximab in Patients Aged Over 80 Years

Diffuse Large B-Cell Lymphoma
SURPRISE Study Group

Completed

Success of Tocilizumab in RA Patients With Remission Induction and Sustained Efficacy After Discontinuation (SURPRISE)

Rheumatoid Arthritis

Japan
AGO Study Group

Completed

Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer

Sarcoma | Cervical Cancer | Ovarian Cancer | Fallopian Tube Cancer | Endometrial Cancer

Germany
Lymphoma Study Association

Completed

Study for Newly Diagnosed Follicular Lymphoma Patients With a Large Tumor Burden

Lymphoma

France, Belgium
AGO Study Group

Completed

Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Patients

Fallopian Tube Neoplasms | Peritoneal Neoplasms | Ovarian Cancer

Germany
Tokyo Study Group

Completed

Intervention to Preserve Beta-Cell Function in GAD Ab-Positive Diabetes

GAD Ab Positive Clinically Type 2 Diabetic Patients

Japan
AGO Study Group

Terminated

Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneum

Anemia | Epithelial Ovarian Cancer, Fallopian Tube or Peritoneum | Platinum Sensitve Relapse

Germany
Lymphoma Study Association

Completed

Randomized Study for Patients With Follicular Lymphoma Needing Treatment

Follicular Lymphoma

France, Belgium
CR-CSSS Champlain-Charles-Le Moyne

Withdrawn

Audit and Feedback Interventions With Primary Care Nursing Teams

Nurse's Role
My Digital Study

Completed

Innovative Digital Therapeutic for Smoking Cessation

Smoking Cessation | Tobacco Smoking | Tobacco Use Disorder | Substance Use Disorder | Drug Addiction | Tobacco Dependence | Drug Dependence | Nicotine Addiction

United States
ALDUS Study Group

Enrolling by invitation

Surveillance Study for HCC by Combining Biomarkers With Imaging (ALDUS) (ALDUS)

Liver Cirrhosis

Japan
Lymphoma Study Association

Terminated

Efficacy and Safety of the Farnesyl-transferase Inhibitor (Tipifarnib) in Mantle Cell Lymphoma

Mantle Cell Lymphoma
AGO Study Group

Completed

Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

Germany
Lymphoma Study Association

Completed

ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma

Diffuse Large Cell Lymphoma

France, Belgium, Switzerland
Bistro Study Group

Completed

Quality of Chest Compressions After a Night Shift (WeCAN)

Cardiac Arrest

France
AGO Study Group

Completed

A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy

Ovarian Cancer | Peritoneal Cancer | Cancer of the Fallopian Tube

Germany
NORDynamIC Study Group

Completed

Multicenter Study Evaluating 12 Versus 24 Weeks Therapy With Peginterferon and Ribavirin for Hepatitis C Virus (HCV) Genotype 2 or 3

Hepatitis C Virus

Sweden
AGO Study Group

Completed

Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer

Ovarian Cancer
AGO Study Group

Completed

Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response

Fallopian Tube Neoplasms | Peritoneal Neoplasms | Ovarian Cancer

Germany
Lymphoma Study Association

Completed

Yttrium-90 Ibritumomab Tiuxetan (Zevalin) With BEAM in Relapsed Low Grade B-Cell Lymphoma

B-Cell Lymphoma

France, Belgium, Switzerland
Lymphoma Study Association

Terminated

Efficacy Study of Rituximab After ASCT in High-Risk Diffuse Large B-Cell Lymphoma

CD20-Positive Large B-Cell Lymphoma

France
Ataxia Study Group

Recruiting

The EUROSCA Natural History Study (EUROSCA-NHS)

Spinocerebellar Ataxia

Austria, Belgium, France, Germany, Hungary, Italy, Netherlands, Poland, Spain, United Kingdom
Huntington Study Group

Completed

Making HD Voices Heard

Huntington Disease

United States
Huntington Study Group

Completed

Development of the Virtual Unified Huntington's Disease Rating Scale (vUHDRS)

Huntington Disease

United States
AGO Study Group

Active, not recruiting

Trial on Radical Upfront Surgery in Advanced Ovarian Cancer (TRUST)

Ovarian Cancer

United States, France, Germany, Austria, Sweden, Denmark, Italy, United Kingdom
Lymphoma Study Association

Completed

Phase II Study to Evaluate the Combination of Rituximab and DepoCyte® in the C5R Chemotherapy Protocol in Patients Between the Ages of 18 and 60 Years With Primary Cerebral Non-Hodgkin Lymphoma and Systemic Diffuse Large B-cell Lymphoma With Neuromeningeal Invasion at Diagnosis

Lymphoma, Non-Hodgkin | Diffuse Large B-cell Lymphoma

Belgium, France
Lymphoma Study Association

Completed

Lenalidomide and R-CHOP in B-cell Lymphoma (R2CHOP-1)

Lymphoma, Large B-Cell, Diffuse | Follicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma

France
Lymphoma Study Association

Completed

Positron Emission Tomography (PET)-Scan in the Evaluation of High Tumor Burden Follicular Lymphoma

Lymphoma, Follicular

France, Italy
AGO Study Group

Completed

Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma

Ovarian Diseases | Ovarian Neoplasms | Endometrial Neoplasms | Genital Diseases, Female

Germany
AGO Study Group

Completed

Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer

Ovarian Cancer | Fallopian Tube Cancer

Germany
AGO Study Group

Completed

Comparison of Paclitaxel/Carboplatin and Lonafarnib to Paclitaxel/Carboplatin for First-line Treatment of Ovarian Cancer

Epithelial Ovarian Cancer

Germany
AGO Study Group

Completed

Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer

Ovarian Cancer

Germany
Famirea Study Group

Terminated

A Communication Strategy for Families of Patients Dying in the ICU

Family of Dying Patient in the ICU
CR-CSSS Champlain-Charles-Le Moyne

Completed

Vancomycin Dose Adjustments Comparing Trough Levels to The AUC/MIC Method Using a Bayesian Approach in a Hospitalized Adult Population (VancoDATABayes)

Adult | Vancomycin | Area Under Curve

Canada
CR-CSSS Champlain-Charles-Le Moyne

Completed

Feasibility of Olanzapine at REduced doSe in hIGHly Emetogenic chemoTherapy (FORESIGHT)

Chemotherapy-induced Nausea and Vomiting

Canada
Guy Waddell
CSSS Chicoutimi

Terminated

The Effect of Post Ablation Medroxyprogesterone Acetate on Endometrial Amenorrhea Rates (MPA postAE)

Menorrhagia

Canada
Klinikum Stuttgart
Klinikum Kassel GmbH (COSS-Biobank)

Not yet recruiting

Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas (COSS-Registry)

Osteosarcoma | High Grade Sarcoma | Recurrent Osteosarcoma | Bone Sarcoma | Undifferentiated Pleomorphic Sarcoma | Bone Tumor | Extraskeletal Osteosarcoma | Osseous Sarcoma | Parosteal Osteosarcoma | Osteoblastic Osteosarcoma | Chondroblastic Osteosarcoma | Fibroblastic Osteosarcoma | Conventional Osteosarcoma | Conventional... and other conditions
Czech Lymphoma Study Group

Not yet recruiting

Study of PV in Combination With Bendamustine and Rituximab for Patients With R/R MCL (CLSGMCLPOLA)

Lymphoma, Mantle-Cell

Czechia
The TIMI Study Group

Completed

Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial (COVID-PACT)

COVID-19 | Venous Thromboembolism | Arterial Thrombosis

United States
German CLL Study Group

Active, not recruiting

Efficacy and Safety of Zanubrutinib Plus Tislelizumab for Treatment of Patients With Richter Transformation (CLL-RT1)

Richter Transformation

Denmark, Germany, Austria
West German Study Group

Active, not recruiting

Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer (ADAPT)

Breast Cancer

Germany
West German Study Group

Active, not recruiting

ADAPT - Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer (ADAPT)

Breast Cancer

Germany

3

Subscribe